FDA Advisors Say New Gene Therapy for Sickle Cell Disease, Exa-cel, is Safe

WEDNESDAY, Nov. 1, 2023 -- A new gene therapy for sickle cell disease was deemed safe by a U.S. Food and Drug Administration advisory panel on Tuesday, paving the way for full approval by early December.
The FDA had already decided that the...